“Imagine the pharmaceutical industry having six FDAs, all competing to approve drugs,” said Rob Dobilas, who founded Realpoint LLC, the credit-rating company bought by Morningstar Inc. in 2010, referring to the U.S. Food and Drug Administration. “Everyone would be dead.”
The rating companies like to hide behind the bogus theory that they provide some kind of objective evaluation on securities when they are in the business of selling their ratings for money. I have news for the CEO"S who testified before Congress, their egregious behavior was exactly who they are. Their behavior reflected their ethics and standards perfectly.
This is so true it's scary... The sooner we can eliminate an outdated perception that ratings exist for the sole benefit of the buyer; the sooner we can build a solid foundation for the securities industry.
ReplyDelete-F
Not only are they selling their rating but the rating doesn't make sense compared with the issue they are rating.
ReplyDelete